| Dr Barrett Eisenstat, MD | |
|
258 Merrick Rd, Oceanside, NY 11572-1427 | |
| (516) 766-0345 | |
| Not Available |
| Full Name | Dr Barrett Eisenstat |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 49 Years |
| Location | 258 Merrick Rd, Oceanside, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285631176 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 130692-2 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| South Nassau Dermatology Pc | 4284525353 | 12 |
News Archive
Previous work by a team of researchers led by Steven N. Fiering, PhD, Immunology and Cancer Immunotherapy researcher at Dartmouth's and Dartmouth-Hitchcock's Norris Cotton Cancer Center and Nicole Steinmetz, PhD, Jacobs School of Engineering and Moores Cancer Center, University of California San Diego, showed that a plant virus that does not infect mammals, cowpea mosaic plant virus (CPMV), when injected into cancerous tumors, strongly stimulated the immune system to attack and often eliminate the tumor.
An estimated 25,000 to 28,000 youth transition out of foster care each year in the United States. In a new study, interviews with hundreds of 17-year-olds in the California foster care system reveal not only elevated mental health counseling and medication use, but also that youth with indicated mental health needs feel less prepared to manage their mental health.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Green Cross Corporation, a leading company in the development, manufacturing, and commercialization of viral vaccines and other biological products, today reported positive clinical data from a Phase 2 trial evaluating JX-594 for liver cancer which was conducted in South Korea.
In a Lancet Comment discussing the WHO Global Tuberculosis report 2013 published today [Wednesday 23 October], members of the UK All-Party Parliamentary Group on Global Tuberculosis and lead author Professor Ali Zumla from University College London sound an alarm as the growing threat of multi-drug resistant TB to regional and global health security becomes more apparent.
GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO's motion to dismiss its litigation over Final Regulations published in August 2007 (Triantafyllos Tafas and SmithKline Beecham Corporation, SmithKline Beecham PLC and Glaxo Group Limited vs. David J. Kappos and the United States Patent and Trademark Office).
› Verified 3 days ago
| Entity Name | South Nassau Dermatology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144272899 PECOS PAC ID: 4284525353 Enrollment ID: O20040320000503 |
News Archive
Previous work by a team of researchers led by Steven N. Fiering, PhD, Immunology and Cancer Immunotherapy researcher at Dartmouth's and Dartmouth-Hitchcock's Norris Cotton Cancer Center and Nicole Steinmetz, PhD, Jacobs School of Engineering and Moores Cancer Center, University of California San Diego, showed that a plant virus that does not infect mammals, cowpea mosaic plant virus (CPMV), when injected into cancerous tumors, strongly stimulated the immune system to attack and often eliminate the tumor.
An estimated 25,000 to 28,000 youth transition out of foster care each year in the United States. In a new study, interviews with hundreds of 17-year-olds in the California foster care system reveal not only elevated mental health counseling and medication use, but also that youth with indicated mental health needs feel less prepared to manage their mental health.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Green Cross Corporation, a leading company in the development, manufacturing, and commercialization of viral vaccines and other biological products, today reported positive clinical data from a Phase 2 trial evaluating JX-594 for liver cancer which was conducted in South Korea.
In a Lancet Comment discussing the WHO Global Tuberculosis report 2013 published today [Wednesday 23 October], members of the UK All-Party Parliamentary Group on Global Tuberculosis and lead author Professor Ali Zumla from University College London sound an alarm as the growing threat of multi-drug resistant TB to regional and global health security becomes more apparent.
GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO's motion to dismiss its litigation over Final Regulations published in August 2007 (Triantafyllos Tafas and SmithKline Beecham Corporation, SmithKline Beecham PLC and Glaxo Group Limited vs. David J. Kappos and the United States Patent and Trademark Office).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Barrett Eisenstat, MD 258 Merrick Rd, Oceanside, NY 11572-1427 Ph: (516) 766-0345 | Dr Barrett Eisenstat, MD 258 Merrick Rd, Oceanside, NY 11572-1427 Ph: (516) 766-0345 |
News Archive
Previous work by a team of researchers led by Steven N. Fiering, PhD, Immunology and Cancer Immunotherapy researcher at Dartmouth's and Dartmouth-Hitchcock's Norris Cotton Cancer Center and Nicole Steinmetz, PhD, Jacobs School of Engineering and Moores Cancer Center, University of California San Diego, showed that a plant virus that does not infect mammals, cowpea mosaic plant virus (CPMV), when injected into cancerous tumors, strongly stimulated the immune system to attack and often eliminate the tumor.
An estimated 25,000 to 28,000 youth transition out of foster care each year in the United States. In a new study, interviews with hundreds of 17-year-olds in the California foster care system reveal not only elevated mental health counseling and medication use, but also that youth with indicated mental health needs feel less prepared to manage their mental health.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Green Cross Corporation, a leading company in the development, manufacturing, and commercialization of viral vaccines and other biological products, today reported positive clinical data from a Phase 2 trial evaluating JX-594 for liver cancer which was conducted in South Korea.
In a Lancet Comment discussing the WHO Global Tuberculosis report 2013 published today [Wednesday 23 October], members of the UK All-Party Parliamentary Group on Global Tuberculosis and lead author Professor Ali Zumla from University College London sound an alarm as the growing threat of multi-drug resistant TB to regional and global health security becomes more apparent.
GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO's motion to dismiss its litigation over Final Regulations published in August 2007 (Triantafyllos Tafas and SmithKline Beecham Corporation, SmithKline Beecham PLC and Glaxo Group Limited vs. David J. Kappos and the United States Patent and Trademark Office).
› Verified 3 days ago
Dr. Eve Lowenstein, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 258 Merrick Rd, Oceanside, NY 11572 Phone: 516-255-0684 | |
Dr. Michael Cohen, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 258 Merrick Rd, Oceanside, NY 11572 Phone: 516-766-0345 Fax: 516-255-5353 | |
Dr. Craig Kornreich, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 258 Merrick Rd, Oceanside, NY 11572 Phone: 516-766-0345 Fax: 516-255-5353 | |
Elie B Lowenstein, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 258 Merrick Rd, Oceanside, NY 11572 Phone: 516-766-0345 Fax: 516-634-0196 | |
Dr. Russell W Cohen, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 258 Merrick Rd, Oceanside, NY 11572 Phone: 516-766-0345 Fax: 516-255-5353 | |
Dr. William Lefing, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 2940 Lower Lincoln Ave, Oceanside, NY 11572 Phone: 516-678-3966 |